
Pfizer Inc. is expected to seek approval this week for emergency use of its booster shots among American teens ages 16-17. Sources familiar with the matter told The New York Times that the U.S. Food and Drug Administration could give the green light in about a week, which would make the Pfizer booster shot the… read on > read on >